SCM
SLS icon

Sterling Capital Management’s SELLAS Life Sciences SLS Stock Holding History

Sterling Capital Management’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.79K Sell
663
-453
-41% -$3.13K ﹤0.01% 2230
2026
Q1 		$4.72K Buy
1,116
+326
+41% +$1.46K ﹤0.01% 2762
2025
Q4 		$2.98K Buy
790
+546
+224% +$1.06K ﹤0.01% 3008
2025
Q3 		$393 Buy
244
+13
+6% +$23 ﹤0.01% 3179
2025
Q2 		$506 Buy
+231
New +$355 ﹤0.01% 3152

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Sterling Capital Management's SLS Position: Q2 2026 in Review

Sterling Capital Management reduced its SELLAS Life Sciences (SLS) stake by 41% in Q2 2026, selling an estimated $3.13K and leaving 663 shares worth $9.79K. The position accounts for ﹤0.01% of the portfolio, ranked #2230.

Sterling Capital Management first reported a position in SLS in Q2 2025 and has held it in 5 quarters since. 192 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Sterling Capital Management held 663 shares of SELLAS Life Sciences worth $9.79K as of Q2 2026.
  • Sterling Capital Management sold 453 SELLAS Life Sciences shares in Q2 2026, an estimated $3.13K.
  • SELLAS Life Sciences made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2230 holding.
  • Sterling Capital Management first reported a position in SELLAS Life Sciences in Q2 2025 and has held it in 5 quarters since.
  • 192 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.